These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15277390)

  • 1. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.
    Carr DB; Utzschneider KM; Hull RL; Kodama K; Retzlaff BM; Brunzell JD; Shofer JB; Fish BE; Knopp RH; Kahn SE
    Diabetes; 2004 Aug; 53(8):2087-94. PubMed ID: 15277390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.
    Barry DR; Utzschneider KM; Tong J; Gaba K; Leotta DF; Brunzell JD; Easterling TR
    Am J Obstet Gynecol; 2015 Jul; 213(1):104.e1-104.e11. PubMed ID: 26003058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bariatric-metabolic surgery on selected components of metabolic syndrome and visceral adipose tissue - the pilot study.
    Horká V; Bužga M; Macháčková J; Holéczy P; Švagera Z
    Physiol Res; 2023 Dec; 72(S5):S523-S534. PubMed ID: 38165756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in peritoneal dialysis patients.
    Li PK; Kwan BC; Szeto CC; Ko GT
    NDT Plus; 2008 Aug; 1(4):206-14. PubMed ID: 25983884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting metabolic syndrome using machine learning - Analysis of commonly used indices.
    Avizohar E; Shehory O
    Health Informatics J; 2023; 29(4):14604582231212521. PubMed ID: 37947787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.
    Alberti KG; Zimmet P; Shaw J
    Diabet Med; 2006 May; 23(5):469-80. PubMed ID: 16681555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
    Alberti KG; Eckel RH; Grundy SM; Zimmet PZ; Cleeman JI; Donato KA; Fruchart JC; James WP; Loria CM; Smith SC; ; ; ; ; ;
    Circulation; 2009 Oct; 120(16):1640-5. PubMed ID: 19805654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome.
    Eckel RH; Grundy SM; Zimmet PZ
    Lancet; 2005 Apr 16-22; 365(9468):1415-28. PubMed ID: 15836891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
    Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F; ;
    Circulation; 2005 Oct; 112(17):2735-52. PubMed ID: 16157765
    [No Abstract]   [Full Text] [Related]  

  • 10. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.
    Pouliot MC; Després JP; Lemieux S; Moorjani S; Bouchard C; Tremblay A; Nadeau A; Lupien PJ
    Am J Cardiol; 1994 Mar; 73(7):460-8. PubMed ID: 8141087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
    Alberti KG; Zimmet PZ
    Diabet Med; 1998 Jul; 15(7):539-53. PubMed ID: 9686693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Banting lecture 1988. Role of insulin resistance in human disease.
    Reaven GM
    Diabetes; 1988 Dec; 37(12):1595-607. PubMed ID: 3056758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).
    Wildman RP; Muntner P; Reynolds K; McGinn AP; Rajpathak S; Wylie-Rosett J; Sowers MR
    Arch Intern Med; 2008 Aug; 168(15):1617-24. PubMed ID: 18695075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of body fat content and distribution on variation in metabolic risk.
    Vega GL; Adams-Huet B; Peshock R; Willett D; Shah B; Grundy SM
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4459-66. PubMed ID: 16926254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
    Eslam M; Newsome PN; Sarin SK; Anstee QM; Targher G; Romero-Gomez M; Zelber-Sagi S; Wai-Sun Wong V; Dufour JF; Schattenberg JM; Kawaguchi T; Arrese M; Valenti L; Shiha G; Tiribelli C; Yki-Järvinen H; Fan JG; Grønbæk H; Yilmaz Y; Cortez-Pinto H; Oliveira CP; Bedossa P; Adams LA; Zheng MH; Fouad Y; Chan WK; Mendez-Sanchez N; Ahn SH; Castera L; Bugianesi E; Ratziu V; George J
    J Hepatol; 2020 Jul; 73(1):202-209. PubMed ID: 32278004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
    Rinella ME; Lazarus JV; Ratziu V; Francque SM; Sanyal AJ; Kanwal F; Romero D; Abdelmalek MF; Anstee QM; Arab JP; Arrese M; Bataller R; Beuers U; Boursier J; Bugianesi E; Byrne CD; Narro GEC; Chowdhury A; Cortez-Pinto H; Cryer DR; Cusi K; El-Kassas M; Klein S; Eskridge W; Fan J; Gawrieh S; Guy CD; Harrison SA; Kim SU; Koot BG; Korenjak M; Kowdley KV; Lacaille F; Loomba R; Mitchell-Thain R; Morgan TR; Powell EE; Roden M; Romero-Gómez M; Silva M; Singh SP; Sookoian SC; Spearman CW; Tiniakos D; Valenti L; Vos MB; Wong VW; Xanthakos S; Yilmaz Y; Younossi Z; Hobbs A; Villota-Rivas M; Newsome PN;
    Ann Hepatol; 2024; 29(1):101133. PubMed ID: 37364816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Loomba R; Ratziu V; Harrison SA;
    Gastroenterology; 2022 Mar; 162(3):680-688. PubMed ID: 34822801
    [No Abstract]   [Full Text] [Related]  

  • 18. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.
    Eslam M; Sarin SK; Wong VW; Fan JG; Kawaguchi T; Ahn SH; Zheng MH; Shiha G; Yilmaz Y; Gani R; Alam S; Dan YY; Kao JH; Hamid S; Cua IH; Chan WK; Payawal D; Tan SS; Tanwandee T; Adams LA; Kumar M; Omata M; George J
    Hepatol Int; 2020 Dec; 14(6):889-919. PubMed ID: 33006093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD.
    Rinella ME; Tacke F; Sanyal AJ; Anstee QM;
    Hepatology; 2019 Oct; 70(4):1424-1436. PubMed ID: 31287572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Global Epidemic of the Metabolic Syndrome.
    Saklayen MG
    Curr Hypertens Rep; 2018 Feb; 20(2):12. PubMed ID: 29480368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.